Disc Medicine, Inc. (IRON)
(Delayed Data from NSDQ)
$51.74 USD
+1.39 (2.76%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $51.75 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Price, Consensus and EPS Surprise
IRON 51.74 +1.39(2.76%)
Will IRON be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IRON based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IRON
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Disc Medicine (IRON) Down on Mixed Results From AURORA Study
IRON: What are Zacks experts saying now?
Zacks Private Portfolio Services
How Much Upside is Left in Disc Medicine, Inc. (IRON)? Wall Street Analysts Think 38.17%
Recent Price Trend in Disc Medicine, Inc. (IRON) is Your Friend, Here's Why
Here's Why Disc Medicine, Inc. (IRON) Is a Great 'Buy the Bottom' Stock Now
Other News for IRON
Disc Medicine to Participate in Upcoming Investor Conferences
TJX downgraded, Crocs upgraded: Wall Street's top analyst calls
Disc Medicine initiated with bullish view at Wells Fargo, here's why
Disc Medicine Breaks Above 200-Day Moving Average - Bullish for IRON
Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Natera (NTRA) and Disc Medicine (IRON)